Maria Książęk

Mrs. Maria Książęk


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2026 in Molecules
Verified
Journal Article
Open access
PDF file
NKNatalia Kurowska
Natalia Kurowska
MKMaria Książęk
Maria Książęk
PBPaulina Borkowska
Paulina Borkowska
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with resistance to 5-fluorouracil (5-FU) representing a major therapeutic challenge. Thymoquinone (TQ), a bioactive constituent of Nigella sativa, exhibits anticancer activity; however, the mechanisms underlying TQ-induced cell death appear to be highly context dependent. This study aimed to characterize cell line-specific death pathways triggered by TQ in colorectal cancer models with distinct molecular backgrounds and differential responsiveness to 5-FU. Human CRC cell lines RKO (5-FU-sensitive) and SW1116 (poorly responsive), along with normal colon epithelial cells (CCD-841CoN), were treated with TQ, 5-FU, or their combination for 24 h. Cell viability, DNA fragmentation, caspase-3/7, -8, and -9 activity, cell death phenotypes, and expression of apoptosis- and necroptosis-related genes were evaluated using MTT assays, ELISA, luminescent assays, flow cytometry, and RT-qPCR. TQ significantly reduced viability in both CRC cell lines while exerting minimal cytotoxicity toward normal cells. In RKO cells, characterized by microsatellite instability (MSI), TQ induced DNA fragmentation, caspase activation, and transcriptional upregulation of pro-apoptotic genes, consistent with apoptosis-associated signaling. In contrast, SW1116 cells, which exhibit chromosomal instability (CIN) and reduced responsiveness to 5-FU, displayed decreased viability accompanied by suppressed caspase activity and predominant features of caspase-independent necrotic cell death. This differential response may be attributed to the CIN phenotype, which has been associated with impaired apoptotic signaling and enhanced tolerance to cytotoxic stress. Combined TQ and 5-FU treatment did not produce synergistic cytotoxicity, as confirmed by Bliss independence analysis, but revealed distinct, cell line-dependent death programs. These findings demonstrate that TQ modulates cell death execution in a molecular context-dependent manner rather than enhancing 5-FU efficacy through pharmacological synergy.

25 September 2026 in Molecules
Verified
Journal Article
Open access
PDF file
NKNatalia Kurowska
Natalia Kurowska
MMMarcel Madej
Marcel Madej
MKMaria Książęk
Maria Książęk
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide. Chronic inflammation plays a pivotal role in CRC development and progression, with cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), and interleukin-8 (IL-8) representing key mediators of tumor-promoting inflammation. This study aimed to evaluate the effects of thymoquinone (TQ), 5-fluorouracil (5-FU), and their combination on the expression of COX-2, IL-6, and IL-8 at both the mRNA and protein levels in colorectal cancer cell lines (SW1116 and RKO) and normal colon epithelial cells (CCD-841CoN). Although numerical changes in inflammation-associated mediator expression were observed following TQ monotherapy, none of the TQ-monotherapy comparisons versus the untreated control reached statistical significance after correction for multiple comparisons. Notably, combined TQ/5-FU treatment significantly reduced COX-2 protein levels in SW1116 cells compared with the untreated control. Differences between transcript and protein responses were observed across the investigated cell lines and treatment conditions. However, since both endpoints were assessed at a single time point, the mechanisms underlying these differences cannot be conclusively determined from the present data. Exploratory molecular docking analysis was additionally performed to examine potential direct interactions of TQ with COX-2, IL-6, and IL-8. The predicted docking scores ranged from −5.1 to −6.6 kcal/mol, with the most favorable predicted interaction observed for COX-2. These computational findings are hypothesis-generating and should be interpreted independently of the experimentally observed changes in target expression. Collectively, the present findings demonstrate treatment- and cell-line-dependent response patterns in inflammation-associated mediators, while providing no statistically significant evidence of an effect of TQ monotherapy versus the untreated control under the present experimental conditions.